Open Access
Efflux Pumps of Mycobacterium tuberculosis play a significant role in anti
TLDR
In this paper, the authors have shown that four efflux pumps of Mycobacterium tuberculosis play a vital role in mediating efflux of 48 different chemical scaffolds, and that inhibitors of one or several of these pumps could have a significant impact in the treatment for tuberculosis.Abstract:
31 32 Active efflux of drugs mediated by efflux pumps which confer drug resistance is one of 33 the mechanisms developed by bacteria to counter the adverse effects of antibiotics and 34 chemicals. To understand these efflux mechanisms in Mycobacterium tuberculosis, we 35 generated knock-out (KO) mutants of four efflux pumps of this pathogen, belonging to 36 different classes. We measured the minimal inhibitory concentrations (MICs) and kill 37 values of two different compound classes on the wild-type (WT) and the efflux pump 38 (EP) KO mutants in the presence and absence of the efflux inhibitors verapamil and L39 phenylalanyl-L-arginyl-β-naphthylamide (PAβN). Among the pumps studied, the efflux 40 pumps belonging to the ABC (ATP-binding cassette) class, encoded by Rv1218c and the 41 SMR (small multidrug resistance) class, encoded by Rv3065 appear to play important 42 roles in mediating efflux of different chemical classes and antibiotics. Efflux pumps 43 encoded by Rv0849 and Rv1258c also mediate efflux of these compounds but to lesser 44 extent. Increased kill is observed in WT M. tuberculosis cells by these compounds in the 45 presence of either verapamil or PAβN. The efflux pump KO mutants were more 46 susceptible to these compounds in the presence of efflux inhibitors. We have shown 47 that these four efflux pumps of M. tuberculosis play a vital role in mediating efflux of 48 different chemical scaffolds. Inhibitors of one or several of these efflux pumps could 49 have a significant impact in the treatment for tuberculosis. 50 Identification and characterization of Rv0849, a new efflux pump belonging 51 to the MFS (major facilitator superfamily) class is reported. 52read more
Citations
More filters
Journal ArticleDOI
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
TL;DR: By far the most widespread mechanism of resistance to AGs is the inactivation of these antibiotics by AG-modifying enzymes, and an overview of these mechanisms is provided.
Journal ArticleDOI
Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
TL;DR: Mechanisms of phenotypic drug tolerance and resistance in bacteria are reviewed with the goal of providing a framework for understanding the similarities and differences in these cells.
Journal ArticleDOI
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux
Richard E. Lee,Julian G. Hurdle,Jiuyu Liu,David F. Bruhn,Tanja Matt,Michael S. Scherman,Pavan K. Vaddady,Zhong Zheng,Jianjun Qi,Rashid Akbergenov,Sourav Das,Dora B. Madhura,Chetan Rathi,Ashit Trivedi,Cristina Villellas,Robin B. Lee,Rakesh,Samanthi L. Waidyarachchi,Dianqing Sun,Michael R. McNeil,José A. Aínsa,Helena I. Boshoff,Mercedes Gonzalez-Juarrero,Bernd Meibohm,Erik C. Böttger,Anne J. Lenaerts +25 more
TL;DR: The antitubercular efficacy of spectinamides demonstrates that synthetic modifications to classical antibiotics can overcome the challenge of intrinsic efflux pump-mediated resistance and expands opportunities for target-based tuberculosis drug discovery.
Journal ArticleDOI
Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital
Mei Deng,Man-Hua Zhu,Jun-Jie Li,Sheng Bi,Zi-Ke Sheng,Fei-Shu Hu,Jia-Jie Zhang,Wei Chen,Xiao-Wei Xue,Jifang Sheng,Lanjuan Li +10 more
TL;DR: This study showed that the active efflux pump AdeABC appeared to play important roles in the tigecycline resistance of A. baumannii, and phenyl-arginine-β-naphthylamide (PAβN) and carbonyl cyanide 3-chlorophenylhydrazone (CCCP) could partially reverse the resistance pattern of tigECYcline.
Journal ArticleDOI
Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation
Christina Kourtesi,Anthony R. Ball,Ying-Ying Huang,Sanjay M Jachak,D Mariano A Vera,Proma Khondkar,Simon Gibbons,Michael R. Hamblin,George P. Tegos +8 more
TL;DR: Advances in the path of EPI discovery are summarized, potential avenues of E PI implementation and development are discussed, and the need for highly informative and comprehensive translational approaches is underlined.
References
More filters
Journal ArticleDOI
Multidrug-resistance efflux pumps ? not just for resistance
TL;DR: Evidence is presented that multidrug-resistance efflux pumps have roles in bacterial pathogenicity and it is proposed that these pumps therefore have greater clinical relevance than is usually attributed to them.
Journal ArticleDOI
Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages Insights into the Phagosomal Environment
Dirk Schnappinger,Sabine Ehrt,Martin I. Voskuil,Yang Liu,Joseph A. Mangan,Irene M. Monahan,Gregory Dolganov,Brad Efron,Philip D. Butcher,Carl Nathan,Gary K. Schoolnik +10 more
TL;DR: The microbial transcriptome served as a bioprobe of the MTB phagosomal environment, showing it to be nitrosative, oxidative, functionally hypoxic, carbohydrate poor, and capable of perturbing the pathogen's cell envelope.
Journal ArticleDOI
Efflux-Mediated Drug Resistance in Bacteria
Xian-Zhi Li,Hiroshi Nikaido +1 more
TL;DR: Fluoroquinolones and β-lactams of the latest generations are likely to select for overproduction mutants of these pumps and make the bacteria resistant in one step to practically all classes of antibacterial agents.
Journal ArticleDOI
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
TL;DR: This review focuses on chromosomally encoded pumps in bacteria that cause infections in humans, and suggests that resistance nodulation division systems are important in pathogenicity and/or survival in a particular ecological niche.
Journal ArticleDOI
Efflux-mediated antimicrobial resistance
TL;DR: Given the clinical significance of multidrug (and drug-specific) exporters, efflux must be considered in formulating strategies/approaches to treating drug-resistant infections, both in the development of new agents less impacted by efflux and in targeting efflux directly with efflux inhibitors.